Clinical Trial Update: Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension [NA]

View source ↗

Summary

This document reports an early feasibility study of the HyperQure Renal Denervation (RDN) system for resistant hypertension, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• HyperQure Renal Denervation System

Snippet

Sponsor: DeepQure Inc. | Conditions: Resistant Hypertension | NA | Status: RECRUITING